Advertisement

Topics

Latest "Mifepristone Cushing Syndrome" News Stories

21:56 EDT 27th September 2016 | BioPortfolio

Here are the most relevant search results for "Mifepristone Cushing Syndrome" found in our extensive news archives from over 250 global news sources.

More Information about Mifepristone Cushing Syndrome on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Mifepristone Cushing Syndrome for you to read. Along with our medical data and news we also list Mifepristone Cushing Syndrome Clinical Trials, which are updated daily. BioPortfolio also has a large database of Mifepristone Cushing Syndrome Companies for you to search.

Showing "Mifepristone Cushing Syndrome" News Articles 1–25 of 2,000+

Extremely Relevant

Children cured of Cushing syndrome still need mental health screening

Primary care physicians caring for children who have been successfully treated for Cushing syndrome should continue screening for mental illness, according to data published in Pediatrics.In an NIH study, the researchers found what they called the first documented evidence of suicide ideation in a subgroup of children and adolescents in remission of Cushing syndrome.


Delayed diagnosis, barriers to care increase morbidity in children with Cushing’s syndrome

Hispanic and black children diagnosed with Cushing’s syndrome are more likely to present with higher cortisol measurements and larger tumor size vs. white children, according to study findings presented at the annual Pediatric Academic Societies Meeting in Baltimore.“Racial and socioeconomic disparities may contribute to the severity of disease presentation for children with Cushing’s [syndr...

VIDEO: Cushing's syndrome still difficult to diagnose

BOSTON — In this video exclusive, Hershel Raff, PhD, professor of medicine, surgery and physiology at the Medical College of Wisconsin and scientific director and clinical research supervisor at Aurora St. Luke’s Medical Center, discusses his presentation on the laboratory diagnosis of Cushing’s syndrome. According to Raff, Cushing’s syndrome is the most enigmatic disease in endocrinology ...


Children with Cushing syndrome may have higher suicide risk

Children with Cushing syndrome may be at higher risk for suicide as well as for depression, anxiety and other mental health conditions long after their disease has been successfully treated, according to a study by researchers at the National Institutes of Health.

Cushing's sx described in infant treated with ophthalmic steroid

(HealthDay)—In a case report published online April 7 in Pediatrics, iatrogenic Cushing's syndrome (ICS) is described in an infant following intranasal usage of dexamethasone ophthalmic solution.

Author Uses Humor to Cope with Rare-Disease Diagnosis

HARRISBURG, Pa. (PRWEB) April 08, 2016 Hoping to help other Cushing’s disease patients and their families, Marie Conley releases her funny, intimate and emotional email exchanges with family and friends in the new book, “ A Cushing’s Collection: A Humorous Journey Surviving Cushing’s Diseas...

Relevant

VIDEO: Late diagnosis of Cushing's disease still a problem

BOSTON — Maria Fleseriu, MD, FACE, professor of medicine and neurologic surgery at Oregon Health Sciences University, discusses her presentation on Cushing’s disease and treatment selection. According to Fleseriu, even 100 years after the discovery of Cushing’s disease, clinicians still struggle with late diagnosis of patients.

Elevated late-night salivary cortisol may indicate recurrent Cushing’s disease

Elevated late-night salivary cortisol may serve as an early biochemical marker of recurrent Cushing’s disease, and prompt intervention may result in clinical benefits for people with Cushing’s disease, according to recent study findings. According to the researchers, late-night salivary cortisol level is more sensitive for detecting Cushing’s disease recurrence compared with urinary free cor...

Surgery Preferred Option in Cushing's Disease for Best Survival

Patients cured of Cushing's disease still face a significantly increased mortality risk more than 10 years later compared with the general population; those who fare best are patients who only have surgery. Medscape Medical News

Radiosurgery in Patients With Acromegaly or Cushing Disease

A new study reports on the incidence of hypopituitarism after gamma knife radiosurgery in patients with acromegaly or Cushing's disease. Clinical Endocrinology

FDA Updates Mifepristone Labeling, Easing Access to Abortion Pill

The Food and Drug Administration has approved new and updated labeling for the medication abortion drug mifepristone (Mifeprex, Danco Laboratories, New York City) to reflect the most current clinical practices and safety and efficacy data. The drug’s new label reduces the size of the initial dose and extends the window for taking it to 70 days since the first day of a woman’s last me...

Pituitary gland: Mortality in Cushing disease

A recent study by Clayton et al. shows that overall mortality is increased for patients with Cushing disease, even in remission, but that mortality is normal if long-term remission is induced by only one pituitary surgery. These findings emphasize the importance of expert pituitary surgery.

HCW starts Strongbridge Biopharma at buy

H.C. Wainwright has initiated coverage of Strongbridge Biopharma (NASDAQ:SBBP) with a “buy” rating and $15 price target. The stock closed at $5.23 on Tuesday. “Within the span of two years, Strongbridge has made material progress to strengthen its rare endocrine portfolio and had strategically planted its footing in a Cushing’s syndrome asset with comparatively low […]

Promising Pre-Clinical and Phase 1 Data Support Advance of Selective Cortisol Modulator CORT125134 as Potential Treatment for Cushing's Syndrome and Solid-Tumor Cancers

MENLO PARK, CA -- (Marketwired) -- 04/28/16 -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of cortisol, today released data supporting the clinical advancement of its proprietary, selective cortisol modulator...

Corcept Therapeutics Appoints Renee D. Gala to Board of Directors

MENLO PARK, CA -- (Marketwired) -- 06/28/16 -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe metabolic, psychiatric and oncologic disorders by modulating the effects of the stress hormone cortisol, announced today that Renée D. Galá has joined the company's Board of Directors. "I...

Corcept Therapeutics Advances Next Generation Drug into Multiple Trials

On April 28, 2016, Corcept Therapeutics (CORT) announced an update of its next generation, selective GR antagonist: CORT125134.       Launched Phase I/II Trial of CORT125134 to treat solid tumors     Will launch Phase II Trial of CORT125134 to treat Cushing’s syndrome in Q2-2016     Underscored CORT125134’s promising profile as seen in animal m...

Corcept Therapeutics Announces First Quarter 2016 Financial Results and Provides Corporate Update

MENLO PARK, CA -- (Marketwired) -- 05/03/16 -- Corcept Therapeutics Incorporated (NASDAQ: CORT) Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of cortisol, today reported its financial results for the quarter e...

Corcept Therapeutics Announces Second Quarter 2016 Financial Results and Provides Corporate Update

MENLO PARK, CA -- (Marketwired) -- 08/02/16 -- Corcept Therapeutics Incorporated (NASDAQ: CORT) Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of cortisol, today reported its financial results for the quarter e...

New report provides insight into burnout syndrome

A new report on burnout syndrome in critical care health care professionals gives key stakeholders guidance on mitigating the development of burnout syndrome and calls for initiating research to examine ways to prevent as well as treat burnout syndrome.

Antiphospholipid syndrome: pathophysiology, diagnosis and treatment

How antiphospholipid syndrome, also known as Hughes syndrome, is diagnosed and the appropriate therapeutic options for its management.

Medical News Today: DiGeorge Syndrome: Causes, Symptoms and Treatment

Learn about DiGeorge syndrome, also known as 22q11.2 deletion syndrome, a chromosomal disorder that causes several body systems to develop poorly.

Corcept Therapeutics Provides Update of Progress in Cortisol Modulation Oncology Program

MENLO PARK, CA -- (Marketwired) -- 06/02/16 -- Corcept Therapeutics Incorporated (NASDAQ: CORT) Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe metabolic, psychiatric and oncologic disorders by modulating the effects of the stress hormone cortisol, released preliminary efficacy data ...

Lynch Syndrome Testing

Lynch syndrome, also known as hereditary nonpolyposis colorectal cancer, is an autosomal-dominant inherited cancer susceptibility syndrome that affects approximately 1 in 35 patients diagnosed with colorectal or endometrial cancers, making it the most common inherited cancer syndrome. Lifetime risk of colorectal cancer for men and women with Lynch syndrome is 10% to 80%, and women with Lynch syndr...

Corcept Therapeutics - Near Term Milestones for the Comeback Kid

Corcept Therapeutics (CORT) has some important milestones arriving within the next three months. The ASCO abstracts were also recently published online. While the actual poster presentation will contain updated information the early signals are still relevant.  If you wish to be updated on Corcept, you may view our commentary on its Q1-2016 results.Phase 1 Safety Results – Hormone Resistant...

D.C. Week: Obama Sets Task Force to Ensure Access to Addiction Tx

(MedPage Today) -- FDA updates its labeling for medical abortion drug mifepristone


Quick Search
Advertisement
 

News Quicklinks